# 510(k) SUMMARY

1. Date:

May 29, 2013

2. Submitter:

Guangzhou Wondfo Biotech Co., Ltd. South China University of Technology Guangzhou, P.R. China 510641

. Contact person:

Joe Shia   
LSI International Inc.   
504 East Diamond Ave., Suite F Gaithersburg, MD 20878   
Telephone: 240-505-7880 7 Fax: 301-916-6213   
Email:shiajl@yahoo.com

4.Device Name:

Wondfo Methadone Urine Test (MTD200) Wondfo Morphine Urine Test (MOP100)

Classification:

<table><tr><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>CFR #</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>DJR</td><td rowspan=1 colspan=1>21 CFR, 862.3620 Methadone TestSystem</td><td rowspan=1 colspan=1>Toxicology•</td></tr><tr><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>21 CFR, 862.3640 Morphine TestSystem</td><td rowspan=1 colspan=1>Toxicology</td></tr></table>

Predicate Devices:

K050394 Medtox Diagnostics Sure-Screen

6. Intended Use

Wondfo Methadone Urine Test (MTD 200) is an immunochromatographic assay for the qualitative determination of Methadone in human urine at a Cut-Off concentration of $2 0 0 ~ \mathrm { \mathfrak { n g / m L } }$ . The test is available in a Dip Card format and a Cup format. This product is only intended for prescription use and is not intended for point-of-care use. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

Wondfo Morphine Urine Test (MOP 100) is an immunochromatographic assay for the qualitative determination of Morphine in human urine at a Cut-Off concentration of $1 0 0 \ \mathrm { n g / m L }$ . The test is available in a Dip Card format and a Cup format. This product is only intended for prescription use and is not intended for point-of-care use.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

# Device Description

Immunochromatographic assays for Methadone and Morphine Urine Tests use a lateral flow, one step system for the qualitative detection of Methadone and Morphine (target analyte) in human urine. Each assay uses a monoclonal antibody-dye conjugate against drugs with gold chloride and fixed drug-protein conjugates and anti-mouse IgG polyclonal antibody in membranes.

# 8. Substantial Equivalence Information

A summary comparison of features of the Wondfo Methadone Urine Test (MTD 200) and Wondfo Morphine Urine Test (MOP 100) and the predicate device is provided in Table 1 & Table 2.

Table 1: Features Comparison of Wondfo Methadone Urine Test (MTD 200) and the Predicate Devices   

<table><tr><td rowspan=1 colspan=1>:iItem         .</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>PredicateK050394</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination ofMethadone in human urine. Forprescription use.</td><td rowspan=1 colspan=1>Same (but thenumber of drugsdetected isdifferent)</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays based onthe principle of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative to indicate positive or negativeresult</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>            Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut-Off Values</td><td rowspan=1 colspan=1>200 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Cup, Dip Card</td><td rowspan=1 colspan=1>Cup</td></tr></table>

Table 2: Features Comparison of Wondfo Morphine Urine Test (MOP 100) and the Predicate Devices   

<table><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate - K050394</td></tr><tr><td colspan="1" rowspan="1">Indication(s)for Use</td><td colspan="1" rowspan="1">For the qualitative determination ofMorphine in human urine. Forprescription use.</td><td colspan="1" rowspan="1">Same(but the numberof drugs detected isdifferent)</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen antibodyimmunochemistry.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Type of Test</td><td colspan="1" rowspan="1">Qualitative to indicate positive ornegative result</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cut-Off Values</td><td colspan="1" rowspan="1">100 ng/mL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Configurations</td><td colspan="1" rowspan="1">Cup, Dip Card</td><td colspan="1" rowspan="1">Cup</td></tr></table>

Test Principle

It is a rapid test for the qualitative detection of Methadone and Morphine in urine samples. It is a lateral flow chromatographic immunoassay. When the absorbent end is immersed into a urine sample, the urine is absorbed into the device by capillary action and mixes with the antibody-dye conjugate, flowing across the pre-coated membrane. At analyte concentration below the target cut off, antibody-dye conjugates bind to the drug-protein conjugate immobilized in the Test Region (T) of the device. This produces a colored test line that indicates a negative result. When analyte concentration is above the cutoff, analyte molecules bind to the antibody-dye conjugate, preventing the antibody-dye conjugate from binding to the drug-protein conjugate immobilized in the Test Region (T) of the device. No colored band shows in the test region, indicating a potentially positive result.

10. Performance Characteristics

1. Analytical Performance

a.Precision

Precision studies were carried out for samples with concentrations of $. 1 0 0 \%$ cut off, $- 7 5 \%$ cut off, $- 5 0 \%$ cut off, $- 2 5 \%$ cut off, $+ 2 5 \%$ cut off, $+ 5 0 \%$ cut off , $+ 7 5 \%$ cut off and $+ 1 0 0 \%$ cut off. These samples were prepared by spiking drug in negative samples. Each drug concentration was confirmed by GC/MS. All sample aliquots were blinded labeled by the person who prepared the samples and that person did not take part in the sample testing. For each concentration, tests were performed two runs per day for 25 days. The results obtained are summarized in the following table.

# Cup Format

MTD 200   

<table><tr><td colspan="1" rowspan="1">ResultMTD 200</td><td colspan="1" rowspan="1">-100%Cut-Off</td><td colspan="1" rowspan="1">-75%Cut-Off</td><td colspan="1" rowspan="1">-50%Cut-Off</td><td colspan="1" rowspan="1">-25%Cut-Off</td><td colspan="1" rowspan="1">Cut-Off</td><td colspan="1" rowspan="1">+25%Cut-Off</td><td colspan="1" rowspan="1">+50%Cut-Off</td><td colspan="1" rowspan="1">+75%Cut-Off</td><td colspan="1" rowspan="1">+100%Cut-Off</td></tr><tr><td colspan="1" rowspan="1">LOTW1570901</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">45+/5-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr><tr><td colspan="1" rowspan="1">ResultMTD 200</td><td colspan="1" rowspan="1">-100%Cut-Off</td><td colspan="1" rowspan="1">-75%Cut-Off</td><td colspan="1" rowspan="1">-50%Cut-Off</td><td colspan="1" rowspan="1">-25%Cutoff</td><td colspan="1" rowspan="1">Cut-Off</td><td colspan="1" rowspan="1">+25%Cut-Off</td><td colspan="1" rowspan="1">+50%Cut-Off</td><td colspan="1" rowspan="1">+75%Cut-Off</td><td colspan="1" rowspan="1">+100%Cut-Off</td></tr><tr><td colspan="1" rowspan="1">CU2</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">LOTW1570902CU2</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">44+/6-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr><tr><td colspan="1" rowspan="1">LOTW1570903CU2</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+.</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">46+/4-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr></table>

MOP 100   

<table><tr><td rowspan=1 colspan=1>ResultMOR TOA</td><td rowspan=1 colspan=1>-100%Cut-OffCut-Off</td><td rowspan=1 colspan=1>-75%Cut-OffCut-Off</td><td rowspan=1 colspan=1>-50%Cut-Off</td><td rowspan=1 colspan=1>-25%Cut-Off</td><td rowspan=1 colspan=1>Cut-Off</td><td rowspan=1 colspan=1>+25%Cut-Off</td><td rowspan=1 colspan=1>+50%Cut-Off</td><td rowspan=1 colspan=1>+75%Cut-Off</td><td rowspan=1 colspan=1>+100%Cut-Off</td></tr><tr><td rowspan=1 colspan=1>LOTW1670901CU2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>46+/4-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1670902CU2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>46+/4-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1670903CU2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>45+/5-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# Dip Card Format

MTD 200   

<table><tr><td rowspan=1 colspan=1>ResultMTD 200</td><td rowspan=1 colspan=1>-100%Cut-Off</td><td rowspan=1 colspan=1>-75%Cut-Off</td><td rowspan=1 colspan=1>-50%Cut-Off</td><td rowspan=1 colspan=1>-25%Cut-Off</td><td rowspan=1 colspan=1>Cut-Off</td><td rowspan=1 colspan=1>+25%Cut-Off</td><td rowspan=1 colspan=1>+50%Cut-Off</td><td rowspan=1 colspan=1>+75%Cut-Off</td><td rowspan=1 colspan=1>+100%Cut-Off</td></tr><tr><td rowspan=1 colspan=1>LOTW1570901P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>45+/5-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1570902P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+·</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>47+/3-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1570903P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>:50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>46+/4-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

MOP 100   

<table><tr><td rowspan=1 colspan=1>ResultMOR 100</td><td rowspan=1 colspan=1>-100%Cut-Off</td><td rowspan=1 colspan=1>-75%Cut-Off</td><td rowspan=1 colspan=1>-50%Cut-Off</td><td rowspan=1 colspan=1>-25%Cut-Off</td><td rowspan=1 colspan=1>Cut-Off</td><td rowspan=1 colspan=1>+25% Cut-of</td><td rowspan=1 colspan=1>+50%Cut-Off</td><td rowspan=1 colspan=1>+75%Cut-Off</td><td rowspan=1 colspan=1>+100%Cut-Off</td></tr><tr><td rowspan=1 colspan=1>LOTW1670901P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>45+/5-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1670902P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>47+/3-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>LOTW1670903P</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>49+/1-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

b. Linearity Not applicable, this is a visually read device   
c.Stability Stable at $4 { - } 3 0 \mathrm { ‰}$ for 18 months based on the accelerated stability study at $5 0 \%$ and real time stability determination at both $4 \%$ and $3 0 \mathrm { ‰}$ .

Cut-off

Total of 150 samples equally distributed at concentrations of $- 5 0 \%$ Cut-Off; $- 2 5 \%$ Cut-Off; Cut-Off; $+ 2 5 \%$ Cut-Off; $+ 5 0 \%$ Cut-Off were tested using three different lots of each device by three different operators. Results were all positive at and above $+ 2 5 \%$ Cut-off and all negative at and below $- 2 5 \%$ Cut-off for both methadone and morphine. The following cut-off values for the test devices have been verified.

<table><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cut-off(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Wondfo Methadone Urine Test (MTD200)</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Wondfo Morphine Urine Test (MOP100)</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>100</td></tr></table>

d. Interference

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and target drugs urine with concentration at $2 5 \%$ below and $2 5 \%$ above Cut-Off level respectively. These urine samples were tested using three batches of each device for both Dip Card and Cup formats.   
Compounds that showed no interference at a concentration of $1 0 0 \mu \mathrm { g / m L }$ are summarized in the following tables. There were no differences observed for both Dip Card and Cup formats.

MTD 200   

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Penicillin-G''</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Pentazocine hydrochloride</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Amitryptyline</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">L-Ascorbic acid</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">DL-Amphetamine sulfate</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Trans-2-phenylcyclo-propylamine hydrochloride</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">L-Phenylephrine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">β-Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">p-Hydroxyamphetamine</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Prednisolone</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Procaine</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">)- Brompheniramine</td><td colspan="1" rowspan="1">(±) - Isoproterenol</td><td colspan="1" rowspan="1">DL-Propranolol</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">D-Propoxyphene</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Quinacrine</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">(±)- Chlorpheniramine</td><td colspan="1" rowspan="1">Mephentermine</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chlorquine</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">(±)-3,4-Methylenedioxy-amphetamine hydrochloride</td><td colspan="1" rowspan="1">Tetrahydrocortisone,3-acetate</td></tr><tr><td colspan="1" rowspan="1">ITemazepam</td><td colspan="1" rowspan="1">(±)-3,4-Methylenedioxy-methamphetamine hydrochloride</td><td colspan="1" rowspan="1">Tetrahydrocortisone3-(β-D-glucuronide)</td></tr><tr><td colspan="1" rowspan="1">Cocaine hydrochloride</td><td colspan="1" rowspan="1">Morphine-3-β-D glucuronide Tetrahydrozoline</td><td colspan="1" rowspan="1">cYanmaGentaYellowb</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Morphine Sulfate</td><td colspan="1" rowspan="1">Thebaine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">(-) Cotinine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">DL-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Tolbutamide</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Norcodein</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Diflunisal                       </td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">DL-Octopamine</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">Oxalic acid</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">(-) -4-Ephedrine</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">[1R,2S] (-) Ephedrine</td><td colspan="1" rowspan="1">Oxolinic acid</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">(L) - Epinephrine</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1"></td></tr></table>

# MOP 100

<table><tr><td colspan="1" rowspan="1">4-Acetamidophenol</td><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">(-) -Y -Ephedrine</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Pentazocine</td></tr><tr><td colspan="1" rowspan="1">Amitryptyline</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">D,L-Amphetamine</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">L-Phenylephrine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">β-Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid /</td><td colspan="1" rowspan="1">p-Hydroxy methamphetamine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">D,L-Propanolol</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">D-Propoxyphene</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin (±)</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">Isoproterenol</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Serotonin(5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">() Chlorpheniramine</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Chlorquine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Tetrahydrocortisone,3 Acetate</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Tetrahydrocortisone3(β-D glucuronide)</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">(+) 3,4-Methylenedioxy-amphetamine</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">(+)3,4-Methylenedioxy-methamphetamine</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Cocaine hydrochloride</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">D, L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">(-) Cotinine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Tolbutamide</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">D, L-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">D,L-Octopamine</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxalic acid</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Zomepirac</td></tr></table>

e.Specificity

To test the specificity, drug metabolites and other components that are likely to interfere in urine samples were tested using three batches of each device for both Dip Card and Cup formats. Compounds that produced positive results are listed below. There were no differences observed for both Dip Card and Cup formats.

MTD 200   

<table><tr><td rowspan=1 colspan=1>MTD(Methadone)(Methadone, Cut-off=200 ng/mL)</td><td rowspan=1 colspan=1>Minimum ConcentrationRequired to Obtain aPositive Result (ng/mL)</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>40,000</td><td rowspan=1 colspan=1>0.5</td></tr></table>

MOP 100   

<table><tr><td>MOR(Morphine) (Morphine, Cut-off=100 ng/mL)</td><td>Minimum Concentration Required to Obtain a</td><td>% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">EY</td><td colspan="1" rowspan="1">Positive Result (ng/mL)</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Hydromorphine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">σ-Monoacetylmorphine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Morphine 3-β-D-glucuronide</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Normorphone</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Oxymorphine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">&lt;1.0</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">2.0</td></tr></table>

1. Effect of Urine Specific Gravity and Urine pH To investigate the effect of urine specific gravity and urine $\mathtt { p H }$ , the urine samples, with $1 . 0 0 0 { \sim } 1 . 0 3 5$ specific gravity or urine samples with $\mathsf { p H 4 } { \sim } \mathsf { 9 }$ were spiked with target drugs at $2 5 \%$ below and $2 5 \%$ above Cut-Off level, respectively. These samples were tested using three batches of each device for both Dip Card and Cup formats. Results were all positive for samples at and above $+ 2 5 \%$ Cut-Off and all negative for samples at and below $- 2 5 \%$ Cut-Off. There were no differences observed for both Dip Card and Cup formats.

# Comparison Studies

The method comparison for the Wondfo Methadone Urine Test (MTD200), Wondfo Morphine Urine Test (MOP100) was performed in-house with three laboratory assistants. Operators ran 80 (40 negative and 40 positive) unaltered clinical samples. The samples were blind labeled and compared to GC/MS results. The results are presented in the table below:

# Cup Format

MTD 200:   

<table><tr><td colspan="2" rowspan="1">Wondfo Result</td><td colspan="1" rowspan="1">Drug-free</td><td colspan="1" rowspan="1">Low Negativeby GC/MS(Less than-50%)</td><td colspan="1" rowspan="1">Near Cut-OffNegative byGC/MS(Between -50%and Cut-Off)</td><td colspan="1" rowspan="1">Near Cut-OffPositive byGC/MS(Between theCut-Off and+50%)</td><td colspan="1" rowspan="1">High Positiveby GC/MS(Greater than+50%)</td></tr><tr><td colspan="1" rowspan="2">Viewer A</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">Viewer C</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></table>

# Dip Card Format

<table><tr><td rowspan=1 colspan=2>Wondfo Result</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>Low Negativeby GC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near Cut-OffNegative byGC/MSBetween -50%and Cut-Off)</td><td rowspan=1 colspan=1>Near Cut-OffPositive byGC/MS(Between theCut-Off and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(Greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>13L</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MTD 200   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cup FormatViewer Result</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTD2061</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTD2063</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTD2061</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTD2063</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTD2063</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>Positive</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Dip Card FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTD2061</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTD2061</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTD2063</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTD2061</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTD2063</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>Positive</td></tr></table>

MOP 100:   

<table><tr><td rowspan=1 colspan=2>Wondfo Result</td><td rowspan=1 colspan=1>rug-free</td><td rowspan=1 colspan=1>Low Negativeby GC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near Cut-OffNegative byGC/MSBetween -50%and Cut-Off)</td><td rowspan=1 colspan=1>Near Cut-OffPositive byGC/MS(Between theCut-Off and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(Greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

# Dip Card Format

<table><tr><td rowspan=1 colspan=2>Wondfo Result</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>Low Negativeby GC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near Cut-OffNegative byGC/MSBetween -50%and Cut-Off)</td><td rowspan=1 colspan=1>Near Cut-OffPositive byGC/MS(Between theCut-Off and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(Greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0&#x27;</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MOP 100   

<table><tr><td>Viewer</td><td>Sample Number</td><td>GC/MS Result</td><td>Cup Format Viewer Result</td></tr><tr><td colspan="1" rowspan="1">Viewer</td><td colspan="1" rowspan="1">Sample Number</td><td colspan="1" rowspan="1">GC/MS Result</td><td colspan="1" rowspan="1">Cup FormatViewer Result</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">OPI1061</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">OPI1215</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">OPI1063</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">OPI1061</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">OPI1215</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">OPI1064</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">OPI1061</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">Positive</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Dip Card FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPI1064</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPI1061</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPI1215</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OPI1063</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OPI1215</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPI1062</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPI1065</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPI1063</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>Positive</td></tr></table>

# 3.Clinical Studies

Not applicable

# 11. Conclusion

Based on the test principle and acceptable performance characteristics including precision, cut-off, interference, specificity and method comparison of the devices, it's concluded that Wondfo Methadone Urine Test (MTD 200), and Wondfo Morphine. Urine Test (MOP 100) are substantially equivalent to the predicate.

May 31, 2013

GE Guangzhou Wondfo Biotech Co., Ltd. C/O Mr. Joe Shia LSI International Inc. 504 East Diamond Ave, Suite F GAITHERSBURG MD 20878

Re: K131232 Trade/Device Name: Wondfo Methadone Urine Test (MTD 200) Wondfo Morphine Urine Test (MOP 100) Regulation Number: 21 CFR 862.3620 Regulation Name: Methadone test system Regulatory Class: II $\cdot$ Product Code: DJR, DJG Dated: April 26, 2013 Received: May 06, 2013

Dear Mr. Shia:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You-may-therefore-market-the-device-subject-to-thegeneral-controls-provisions-of-the-ActThegeneral controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2—Mr. Shia

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffces/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

7.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. 1

Sincerely yours,

# Carol Benson -Sfor

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): K131232

# Device Name: Wondfo Methadone Urine Test (MTD 200) Wondfo Morphine Urine Test (MOP 100)

Indications for Use:

Wondfo Methadone Urine Test (MTD 200)

Wondfo Methadone Urine Test (MTD 200) is an immunochromatographic assay for the qualitative determination of Methadone in human urine at a Cut-Off concentration of 200 $\mathfrak { n g / m L }$ . The test is available in a Dip Card format and a Cup format. This product is only intended for prescription use and is not intended for point-of-care use.

The test provides only preliminary test results. A more specific altermative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

# Indications for Use

510(k) Number (if known): K131232

# Device Name: Wondfo Methadone Urine Test (MTD 200) Wondfo Morphine Urine Test (MOP 100)

Indications for Use:

Wondfo Morphine Urine Test (MOP 100)

Wondfo Morphine Urine Test (MOP 100) is an immunochromatographic assay for the qualitative determination of Morphine in human urine at a Cut-Off concentration of 100 $\mathfrak { n g / m L }$ .The test is available in a Dip Card format and a Cup format. This product is only intended for prescription use and is not intended for point-of-care use.

The test provides only preliminary test results. A more specific altemnative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)